此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

阿米万他单抗和卡铂-培美曲塞联合疗法的研究,与卡铂-培美曲塞相比,在以表皮生长因子受体 (EGFR) 外显子 20 插入为特征的晚期或转移性非小细胞肺癌参与者中的研究 (PAPILLON)

2026年11月2日 更新者:Janssen Research & Development, LLC

61186372NSC3001: A Randomized, Open-label Phase 3 Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Patients With EGFR Exon 20ins Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

The purpose of this study is to compare the efficacy, as demonstrated by progression-free survival (PFS), in participants treated with amivantamab in combination with chemotherapy, versus chemotherapy alone in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) characterized by EGFR Exon 20ins mutations.

研究概览

研究类型

介入性

注册 (实际的)

308

阶段

  • 第三阶段

扩展访问

得到正式认可的 出售给公众。 查看扩展访问记录。

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Beijing、中国、100142
        • Beijing Cancer Hospital
      • Beijing、中国、100853
        • Chinese PLA General Hospital
      • Beijing、中国、102206
        • Peking University International Hospital
      • Beijing、中国、100142
        • Beijing Cancer Hospital Chest Tumor Internal Medicine dept. II
      • Beijing、中国、101199
        • Beijing Chest hospital, Capital medical university
      • Changchun、中国、130000
        • Jilin cancer hospital
      • Changsha、中国、410013
        • Hunan Cancer Hospital Chest Tumor Internal Medicine dept. II
      • Changsha、中国、410013
        • Hunan Cancer hospital
      • Changzhou、中国、213003
        • The First People's Hospital Of Changzhou
      • Chengdu、中国、610041
        • West China Hospital Sichuan University
      • Chongqing、中国、400030
        • Chongqing University Cancer Hospital
      • Fuzhou、中国、350001
        • Fujian Medical University Union Hospital
      • Guangzhou、中国、510080
        • The First Affiliated Hospital Sun Yat sen University
      • Hangzhou、中国、310022
        • Zhejiang Cancer Hospital
      • Hangzhou、中国、310009
        • The Second Affiliated Hospital of Zhejiang University College of Medicine
      • Hangzhou、中国、310003
        • The First Affiliated Hospital Zhejiang University College of Medicine
      • Hangzhou、中国、310016
        • Sir Run Run Shaw Hospital Zhejiang University School of Medicine
      • Hangzhou、中国、310009
        • The Second Affiliated Hospital of Zhejiang University College of Medicine 1
      • Harbin、中国、150000
        • Harbin medical university cancer hospital
      • Linhai、中国、317000
        • Taizhou Hospital of Zhejiang Province
      • Nanjing、中国、210031
        • Nanjing Drum Tower Hospital
      • Shanghai、中国、200030
        • Shanghai Chest Hospital
      • Shanghai、中国、200032
        • Fudan University Shanghai Cancer Center
      • Shanghai、中国、200433
        • Shanghai Pulmonary Hospital
      • Shanghai、中国、200123
        • Shanghai East Hospital
      • Shenyang、中国、110004
        • Shengjing Hospital Of China Medical University
      • Shenzhen、中国、518116
        • Cancer hospital Chinese Academy of Medical Sciences, Shenzhen Center
      • Tianjin、中国、300052
        • Tianjin Medical University General Hospital
      • Weifang、中国、261000
        • Weifang People's Hospital
      • Wuhan、中国、430030
        • TongJi Hospital of TongJi Medical College of Huazhong University of Science & Technology
      • Wuxi、中国、214122
        • Hospital of Jiangnan University
      • Xi'an、中国、710061
        • The First Affiliated Hospital of Xian Jiaotong University
      • Yantai、中国、264000
        • Yantai Yuhuangding Hospital
      • Zhengzhou、中国、450008
        • Henan Cancer Hospital
      • Dnipro、乌克兰、49102
        • Dnipropetrovsk State Medical Academy, Dnipropetrovsk City Multifield Clinical Hospital # 4
      • Kyiv、乌克兰、02091
        • Medical Center 'Ok Clinic' of LLC 'International Institute of Clinical Studies'
      • Kyiv、乌克兰、03022
        • National Cancer Institute
      • Jerusalem、以色列、91031
        • Shaare Zedek Medical Center
      • Jerusalem、以色列、9112001
        • Hadassah Medical Center
      • Kfar Saba、以色列、44281
        • Meir Medical Center
      • Petah Tikva、以色列、49100
        • Rabin Medical Center
      • Tel Aviv、以色列、6423906
        • Tel Aviv Sourasky Medical Center
      • Irkutsk、俄罗斯、664035
        • Irkutsk Regional Oncology Dispensary
      • Krasnogorsk、俄罗斯、143423
        • Moscow City Oncology Hospital No 62
      • Krasnoyarsk、俄罗斯、660133
        • Krasnoyarsk Regional Oncology Dispensary
      • Kuzmolovsky、俄罗斯、188663
        • Leningrad Regional Oncology Dispensary
      • Moscow、俄罗斯、115533
        • MCK
      • Nal'chik、俄罗斯、360000
        • City Clinical Hospital #1
      • Nizhny Novgorod、俄罗斯、603000
        • Nizhny Novgorod Regional Oncological Dispensary
      • Saint Petersburg、俄罗斯、197758
        • N.N. Petrov Research Institute Of Oncology
      • Saint Petersburg、俄罗斯、194291
        • Leningrad Regional Clinical Hospital
      • Saint Petersburg、俄罗斯、196006
        • Oncology Medical Clinics AV Medical group
      • Tomsk、俄罗斯、634050
        • Tomsk Cancer Research Institute
      • Ufa、俄罗斯、450083
        • Bashkir State Medical University
      • Yaroslavl、俄罗斯、150054
        • Yaroslavl Regional Clinical Oncology Hospital
    • Ontario
      • Ottawa、Ontario、加拿大、K1H 8L6
        • The Ottawa Hospital Cancer Centre
      • Toronto、Ontario、加拿大、M4N 3M5
        • Sunnybrook Health Sciences Centre
    • Quebec
      • Montreal、Quebec、加拿大、H4A 3J1
        • McGill University Health Centre
      • Budapest、匈牙利、H-1529
        • Orszagos Koranyi Tbc es Pulmonologiai Intezet
      • Gyöngyös、匈牙利、3233
        • Mátrai Gyógyintézet-Bronchológia
      • Szombathely、匈牙利、9700
        • Markusovszky Egyetemi Oktatokorhaz
      • Székesfehérvár、匈牙利、8000
        • Fejer Varmegyei Szent Gyorgy Egyetemi Oktatokorhaz
      • Törökbálint、匈牙利、2045
        • Tudogyogyintezet Torokbalint
      • Hyderabad、印度、500034
        • Basavatarakam Indo-American Hospital
      • Kolkata、印度、700160
        • Tata Medical Center
      • Mumbai、印度、400012
        • Tata Memorial Hospital
      • Nashik、印度、422002
        • HCG Manavta Cancer Centre
      • New Delhi、印度、110085
        • Rajiv Gandhi Cancer Institute & Research Centre
      • Pune、印度、411013
        • Noble Hospital Pvt Ltd
      • Kaohsiung City、台湾、807
        • Kaohsiung Medical University Chung Ho Memorial Hospital
      • Kaohsiung City、台湾、833
        • Chang Gung Medical Foundation
      • New Taipei City、台湾、23561
        • Taipei Medical University Shuang Ho Hospital
      • Taichung、台湾、40447
        • China Medical University Hospital
      • Taichung、台湾、402
        • Chung Shan Medical University Hospital
      • Taipei、台湾、10002
        • National Taiwan University Hospital
      • Adana、土耳其(türkiye)、01060
        • Adana City Hospital
      • Adana、土耳其(türkiye)、01250
        • Başkent University Medical Faculty Adana Application and Research Center
      • Ankara、土耳其(türkiye)、6560
        • Gazi University Hospital
      • Ankara、土耳其(türkiye)、6800
        • Ankara Bilkent City Hospital
      • Edirne、土耳其(türkiye)、22030
        • Trakya University Medical Faculty
      • Istanbul、土耳其(türkiye)、34722
        • Goztepe Prof Dr Suleyman Yalcin Sehir Hastanesi
      • Istanbul、土耳其(türkiye)、34098
        • Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd
      • Istanbul、土耳其(türkiye)、34214
        • Medipol Mega University Hospital
      • Izmir、土耳其(türkiye)、35580
        • Izmir Medical Park Hospital
      • Chihuahua City、墨西哥、31217
        • Centro Oncologico de Chihuahua
      • Guadalajara、墨西哥、44280
        • Hospital Civil de Guadalajara Fray Antonio Alcalde
      • Mexico City、墨西哥、14080
        • Instituto Nacional de Cancerologia
      • Mexico City、墨西哥、14050
        • Médica Sur
      • Mexico City、墨西哥、03100
        • Mexico Centre for Clinical Research, S.A. de C.V.
      • Monterrey、墨西哥、64710
        • i Can Oncology Center
      • México、墨西哥、03100
        • Health Pharma Professional Research
      • Naucalpan、墨西哥、53100
        • Oncologia Integral Satelite
      • Barretos、巴西、14784-400
        • Fundacao Pio XII
      • Belo Horizonte、巴西、30110-017
        • Cetus Oncologia
      • Florianópolis、巴西、88020-210
        • Ynova Pesquisa Clinica
      • Ijuí、巴西、98700-000
        • Oncosite - Centro de Pesquisa Clínica em Oncologia Ltda
      • Natal、巴西、59062 000
        • Liga Norte Riograndense Contra O Cancer
      • Pelotas、巴西、96020 080
        • UPCO Unidade de Pesquisa Clinica em Oncologia
      • Porto Alegre、巴西、90020-090
        • Irmandade Santa Casa de Misericordia de Porto Alegre
      • Porto Alegre、巴西、90610-000
        • Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS
      • Rio de Janeiro、巴西、22 250 905
        • Oncoclinicas Rio de Janeiro S A
      • Rio de Janeiro、巴西、22281 100
        • Instituto D Or de Pesquisa e Ensino IDOR
      • Rio de Janeiro、巴西、20231 050
        • Ministerio da Saude Instituto Nacional do Cancer
      • Sorocaba、巴西、18030-075
        • IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado
      • São Paulo、巴西、04014-002
        • Núcleo de Pesquisa São Camilo
      • São Paulo、巴西、01509 900
        • Fundacao Antonio Prudente A C Camargo Cancer Center
      • São Paulo、巴西、01246 000
        • Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo
      • Vitória、巴西、29308-014
        • Hospital Evangélico de Cachoeiro de Itapemirim
      • Bad Berka、德国、99437
        • Zentralklinik Bad Berka GmbH
      • Berlin、德国、13125
        • Evangelische Lungenklinik Berlin
      • Cologne、德国、50937
        • Universitaetsklinikum Koeln
      • Cologne、德国、51109
        • Kliniken der Stadt Koeln gGmbH
      • Gauting、德国、82131
        • Asklepios Klinik Gauting GmbH - Asklepios Fachkliniken Munchen-Gauting
      • Heidelberg、德国、69126
        • Thoraxklinik am Universitatsklinikum Heidelberg
      • Heilbronn、德国、74072
        • Onkologische Schwerpunktpraxis
      • Moers、德国、47441
        • Bethanien Krankenhaus
      • Oldenburg、德国、26121
        • Pius-Hospital Oldenburg
      • Recklinghausen、德国、45659
        • Oncologianova GmbH
      • Bologna、意大利、40138
        • A O U Sant Orsola Malpighi
      • Catania、意大利、95123
        • Azienda Ospedaliero Univ. Policlinico Gaspare Rodolico
      • Meldola、意大利、47014
        • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
      • Milan、意大利、20132
        • IRCCS Ospedale San Raffaele
      • Milan、意大利、20133
        • Fondazione IRCCS Istituto Nazionale dei Tumori
      • Milan、意大利、20122
        • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
      • Monza、意大利、20052
        • San Gerardo Hospital
      • Ravenna、意大利、48121
        • Ospedale S. Maria Delle Croci
      • Roma、意大利、00168
        • Irccs Gemelli
      • Rozzano、意大利、20089
        • Istituto Clinico Humanitas
      • Bunkyō City、日本、113 8431
        • Juntendo University Hospital
      • Hidaka、日本、350-1298
        • Saitama Medical University International Medical Center
      • Himeji、日本、670-8520
        • National Hospital Organization Himeji Medical Center
      • Hirakata、日本、573 1191
        • Kansai Medical University Hospital
      • Kanazawa、日本、920 8641
        • Kanazawa University Hospital
      • Kashiwa、日本、277 8577
        • National Cancer Center Hospital East
      • Kishiwada、日本、596-8501
        • Kishiwada City Hospital
      • Kobe、日本、650-0047
        • Kobe City Medical Center General Hospital
      • Kurashiki、日本、710-8602
        • Kurashiki Central Hospital
      • Kurume、日本、830-0011
        • Kurume University Hospital
      • Matsusaka、日本、515-8544
        • Matsusaka Municipal Hospital
      • Nagoya、日本、460-0001
        • National Hospital Organization Nagoya Medical Center
      • Nagoya、日本、464 8681
        • Aichi Cancer Center Hospital
      • Niigata、日本、951-8566
        • Niigata Cancer Center Hospital
      • Osaka Sayama Shi、日本、589 8511
        • Kindai University Hospital
      • Sagamihara、日本、252-0375
        • Kitasato University Hospital
      • Sapporo、日本、060-8648
        • Hokkaido University Hospital
      • Shiwa-gun、日本、028-3695
        • Iwate Medical University Hospital
      • Shizuoka、日本、411 8777
        • Shizuoka Cancer Center
      • Tokyo、日本、135 8550
        • The Cancer Institute Hospital of JFCR
      • Toon-shi、日本、791-0295
        • Ehime University Hospital
      • Wakayama、日本、641 8510
        • Wakayama Medical University Hospital
      • Yamaguchi、日本、755-0241
        • National Hospital Organization Yamaguchi Ube Medical Center
      • Leuven、比利时、3000
        • UZ Leuven
      • Roeselare、比利时、8800
        • Algemeen Ziekenhuis Delta
      • Yvoir、比利时、5530
        • CHU UCL Namur - Site Godinne
      • Bordeaux、法国、33000
        • Institut Bergonie
      • Bron、法国、69500
        • Hospices Civils de Lyon HCL
      • Dijon、法国、21000
        • Centre Georges Francois Leclerc
      • Le Mans、法国、72037
        • Centre Hospitalier Le Mans
      • Lille、法国、59037
        • CHR Hôpital Calmette
      • Nantes、法国、44093
        • CHU Nantes - Hopital Nord Laënnec
      • Paris、法国、75005
        • Institut Curie
      • Pessac、法国、33604
        • CHU Bordeaux
      • Saint-Mandé、法国、94163
        • HIA Begin
      • Bydgoszcz、波兰、85 796
        • Centrum Onkologii im Prof F Lukaszczyka
      • Gdansk、波兰、80 214
        • Uniwersyteckie Centrum Kliniczne
      • Gdynia、波兰、81 519
        • Szpitale Pomorskie Sp z o o
      • Olsztyn、波兰、10-357
        • Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie
      • Poznan、波兰、60-693
        • Private Specialist Hospitals - MedPolonia
      • Warsaw、波兰、02-781
        • Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
      • Rio Piedras、波多黎各、00935
        • Pan American Center for Oncology Trials LLC
      • Bangkok、泰国、10700
        • Siriraj Hospital
      • Bangkok、泰国、10400
        • Phramongkutklao Hospital and Medical College
      • Songkhla、泰国、90110
        • Songklanagarind Hospital, Prince of Songkla University
      • Camperdown、澳大利亚、2050
        • Chris O'Brien Lifehouse
      • Kogarah、澳大利亚、2217
        • St George Hospital
      • Malvern、澳大利亚、3144
        • Cabrini Medical Centre
      • Nedlands、澳大利亚、6009
        • Sir Charles Gairdner Hospital
    • California
      • Duarte、California、美国、91010
        • City of Hope 2
      • Orange、California、美国、92868
        • University of California Irvine
      • Santa Monica、California、美国、90404
        • UCLA
    • District of Columbia
      • Washington D.C.、District of Columbia、美国、20007
        • Georgetown University Hospital
    • Florida
      • Tampa、Florida、美国、33612
        • H. Lee Moffitt Cancer & Research Institute
    • Georgia
      • Athens、Georgia、美国、30607
        • University Cancer And Blood Center LLC
    • Michigan
      • Detroit、Michigan、美国、48202
        • Henry Ford Hospital
    • Missouri
      • St Louis、Missouri、美国、63110
        • Washington University Medical Center
    • New Jersey
      • East Brunswick、New Jersey、美国、08816
        • Regional Cancer Care Associates LLC
    • New York
      • New York、New York、美国、10032
        • Columbia University Medical Center
      • New York、New York、美国、10016
        • Langone Health at NYC University, NYU School of Medicine
    • Oregon
      • Portland、Oregon、美国、97213
        • Providence Portland Medical Center
    • South Dakota
      • Sioux Falls、South Dakota、美国、57104
        • Sanford Health
    • Texas
      • Tyler、Texas、美国、75702
        • Texas Oncology Pa
    • Utah
      • Salt Lake City、Utah、美国、84106
        • Utah Cancer Specialists
    • Virginia
      • Fairfax、Virginia、美国、22031
        • Virginia Cancer Specialists
      • Salem、Virginia、美国、24153
        • Blue Ridge Cancer Care
      • Edinburgh、英国、EH4 2XU
        • Edinburgh Cancer Centre Western General
      • London、英国、SW3 6JJ
        • The Royal Marsden NHS Trust Chelsea
      • Sutton、英国、SM2 5PT
        • The Royal Marsden NHS Trust Sutton
      • Lisbon、葡萄牙、G1R 2J6
        • Uls Sao Jose - Hosp. Sto Antonio Dos Capuchos
      • Lisbon、葡萄牙、1998-018
        • Hosp. Cuf Descobertas
      • Porto、葡萄牙、4200-072
        • Instituto Portugues de Oncologia
      • Porto、葡萄牙、4099-001
        • Centro Hospitalar Universitario do Porto, EPE
      • Vila Nova de Gaia、葡萄牙、4434 502
        • Centro Hospitalar de Vila Nova de Gaia Espinho E P E
      • A Coruña、西班牙、15006
        • Hosp Univ A Coruna
      • Badalona、西班牙、08916
        • Inst. Cat. D'Oncologia-Badalona
      • Barcelona、西班牙、08025
        • Hosp. de La Santa Creu I Sant Pau
      • Barcelona、西班牙、08028
        • Hosp. Univ. Quiron Dexeus
      • Barcelona、西班牙、08035
        • Hosp Univ Vall D Hebron
      • Burgos、西班牙、09003
        • Hosp. Univ. de Burgos
      • Madrid、西班牙、28041
        • Hosp. Univ. 12 de Octubre
      • Madrid、西班牙、28034
        • Hosp. Univ. Ramon Y Cajal
      • Madrid、西班牙、28046
        • Hosp. Univ. La Paz
      • Madrid、西班牙、28007
        • Hosp. Gral. Univ. Gregorio Maranon
      • Majadahonda、西班牙、28222
        • Hosp. Univ. Pta. de Hierro Majadahonda
      • Málaga、西班牙、29010
        • Hosp Virgen de La Victoria
      • Pamplona、西班牙、31008
        • Clinica Univ. de Navarra
      • Seville、西班牙、41013
        • Hosp. Virgen Del Rocio
      • Zaragoza、西班牙、50009
        • Hosp. Clinico Univ. Lozano Blesa
      • Busan、韩国、48108
        • Inje University Haeundae Paik Hospital
      • Gyeonggi-do、韩国、10408
        • National Cancer Center 1
      • Gyeongsangnam-do、韩国、52727
        • GyeongSang National University Hospital
      • Jeollanam-do、韩国、58128
        • Chonnam National University Hwasun Hospital
      • Seongnam-si、韩国、13620
        • Seoul National University Bundang Hospital
      • Seoul、韩国、05505
        • Asan Medical Center
      • Seoul、韩国、03722
        • Severance Hospital Yonsei University Health System
      • Seoul、韩国、06351
        • Samsung Medical Center
      • Seoul、韩国、03181
        • Kangbuk Samsung Hospital
      • Seoul、韩国、02841
        • Korea University Anam Hospital
      • Seoul、韩国、06591
        • The Catholic University of Korea Seoul St Mary s Hospital
      • George Town、马来西亚、10990
        • Hospital Pulau Pinang
      • Johor Bahru、马来西亚、81100
        • Hospital Sultan Ismail
      • Kuala Lumpur、马来西亚、50586
        • Hospital Kuala Lumpur
      • Kuala Lumpur、马来西亚、59100
        • University Malaya Medical Centre

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Participant must have histologically or cytologically confirmed, locally advanced or metastatic, nonsquamous non-small cell lung cancer (NSCLC) with documented primary epidermal growth factor receptor (EGFR) Exon 20ins activating mutation
  • Participant must have measurable disease according to Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.
  • Participant must have Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
  • Participant must agree to genetic characterization of tumor status through the required pretreatment tumor biopsy (or submission of equivalent archival material), as well as baseline and periodic blood samples for analysis of tumor mutations in the bloodstream
  • A female participant of childbearing potential must have a negative serum or urine test at screening and within 72 hours of the first dose of study treatment and must agree to further serum or urine pregnancy tests during the study

Exclusion Criteria:

  • Participant has evidence of synchronous NSCLC disease (as suggested by genetic characterization or radiographic appearance)
  • Participant has untreated brain metastases (a participant with definitively, locally treated metastases who is clinically stable, asymptomatic, and off corticosteroid treatment for at least 2 weeks prior to randomization is eligible)
  • Participant has history of spinal cord compression that has not been treated definitively with surgery or radiation
  • Participant has a medical history of interstitial lung disease (ILD), including drug-induced ILD, or radiation pneumonitis
  • Participant has a contraindication to the use of carboplatin or pemetrexed (refer to local prescribing information for each agent). Participant has a history of hypersensitivity to, or cannot take, vitamin B12 or folic acid

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Arm A: Amivantamab + Chemotherapy

Participants will receive pemetrexed 500 milligram per meter square (mg/m^2) intravenous (IV) infusion (with vitamin supplementation) on Day 1 of each 21-day cycle, in combination with carboplatin for up to 4 cycles, and then as maintenance monotherapy until disease progression. Carboplatin area under the concentration-time curve 5 milligram per milliliter (mg/mL) per minute (AUC 5) will be administered as IV infusion on Day 1 of each 21 day cycle, for up to 4 cycles. Participants will receive amivantamab 1400 mg (1750 mg if body weight is >=80 kilogram [kg]) by IV infusion once weekly up to Cycle 2 Day 1, then 1750 mg (2100 mg if body weight is >=80 kg) on Day 1 of each 21-day cycle, starting with Cycle 3. Following the primary analysis for efficacy, the study will transition to an OLE phase and participants will continue to receive the amivantamab plus chemotherapy in OLE phase. Participants who completed OLE period will enter LTE period and continue to receive same treatment.

Amivantamab will be administered as an IV infusion at a dose of 1400 mg (1750 mg if body weight is >=80 kilogram [kg]) by once weekly up to Cycle 2 Day 1, then 1750 mg (2100 mg if body weight is >=80 kg) on Day 1 of each 21-day cycle, starting with Cycle 3 and will continue the same treatment in OLE phase then in LTE phase.

其他名称:
  • JNJ-61186372

Pemetrexed will be administered as 500 mg/m^2 IV infusion (with vitamin supplementation) on Day 1 of each 21-day cycle and then as maintenance monotherapy until disease progression in Arm A and will continue the same treatment in OLE phase then in LTE phase.

Carboplatin will be administered as AUC 5 IV infusion for up to 4 cycles on Day 1 of each 21-day cycle.

Pemetrexed will be administered as 500 mg/m^2 IV infusion (with vitamin supplementation) on Day 1 of each 21-day cycle and then as maintenance monotherapy until disease progression in Arm B and will continue the same treatment in OLE phase then in LTE phase.

实验性的:Arm B: Chemotherapy Alone

Participants will receive pemetrexed 500 mg/m^2 IV infusion (with vitamin supplementation) on Day 1 of each 21-day cycle, in combination with carboplatin for up to 4 cycles, and then as maintenance monotherapy until disease progression. Carboplatin AUC 5 IV infusion will be administered on Day 1 of each 21-day cycle for up to 4 cycles. Following the primary analysis for efficacy, the study will transition to an OLE phase and participants will either continue to receive the chemotherapy or cross over to amivantamab in OLE phase. Participants who completed OLE period will enter LTE period and continue to receive same treatment.

Pemetrexed will be administered as 500 mg/m^2 IV infusion (with vitamin supplementation) on Day 1 of each 21-day cycle and then as maintenance monotherapy until disease progression in Arm A and will continue the same treatment in OLE phase then in LTE phase.

Carboplatin will be administered as AUC 5 IV infusion for up to 4 cycles on Day 1 of each 21-day cycle.

Pemetrexed will be administered as 500 mg/m^2 IV infusion (with vitamin supplementation) on Day 1 of each 21-day cycle and then as maintenance monotherapy until disease progression in Arm B and will continue the same treatment in OLE phase then in LTE phase.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Progression-Free Survival (PFS) According to Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 as Assessed by Blinded Independent Central Review (BICR)
大体时间:From randomization to either disease progression or death whichever occurs first (up to 29 months)

PFS was defined as the time from randomization until the date of objective disease progression based on BICR using RECIST version 1.1 or death (by any cause) in the absence of progression, whichever came first. Participants who have not progressed or have not died at the time of analysis were censored at the time of the latest date of their last evaluable RECIST version 1.1 assessment. Pharmacodynamic: Sum of diameters increased by greater than or equal to (>=)20 percent (%) and >=5 millimeter (mm) from nadir (including baseline if it was smallest sum).

From randomization to either disease progression or death whichever occurs first (up to 29 months)

次要结果测量

结果测量
大体时间
客观缓解率 (ORR)
大体时间:最长5年3个月
最长5年3个月
响应持续时间 (DoR)
大体时间:最长5年3个月
最长5年3个月
总生存期 (OS)
大体时间:最长5年3个月
最长5年3个月
后续治疗时间 (TST)
大体时间:最长5年3个月
最长5年3个月
首次后续治疗后的无进展生存期 (PFS2)
大体时间:最长5年3个月
最长5年3个月
症状进展时间 (TTSP)
大体时间:最长5年3个月
最长5年3个月
参与者数量 治疗中出现的不良事件 (TEAE)
大体时间:从第 1 天到 5 年 2 个月
从第 1 天到 5 年 2 个月
严重程度 TEAE 的参与者数量
大体时间:从第 1 天到 5 年 2 个月
从第 1 天到 5 年 2 个月
临床实验室异常的参与者人数
大体时间:最长5年3个月
最长5年3个月
生命体征异常的参与者人数
大体时间:最长5年3个月
最长5年3个月
体检异常人数
大体时间:最长5年3个月
最长5年3个月
阿米凡他单抗的血清浓度
大体时间:第 1 天(第 1、2、3、5、7、9、11、13 周期)、第 2 天(第 1 周期)
第 1 天(第 1、2、3、5、7、9、11、13 周期)、第 2 天(第 1 周期)
具有抗阿米万他抗体的参与者人数
大体时间:第 1 天(第 1、2、3、5、7、9、11、13 周期)、第 2 天(第 1 周期)
第 1 天(第 1、2、3、5、7、9、11、13 周期)、第 2 天(第 1 周期)
欧洲癌症研究和治疗组织生活质量问卷核心 30 (EORTC-QLQ-C30) 相对于基线的变化
大体时间:从基线到 5 年 3 个月
从基线到 5 年 3 个月
患者报告结果测量信息系统 - 身体功能 (PROMIS-PF) 相对于基线的变化
大体时间:从基线到 5 年 3 个月
从基线到 5 年 3 个月

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Janssen Research & Development, LLC Clinical Trial、Janssen Research & Development, LLC

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2020年10月13日

初级完成 (实际的)

2023年5月3日

研究完成 (估计的)

2027年12月31日

研究注册日期

首次提交

2020年8月31日

首先提交符合 QC 标准的

2020年8月31日

首次发布 (实际的)

2020年9月4日

研究记录更新

最后更新发布 (实际的)

2026年11月3日

上次提交的符合 QC 标准的更新

2026年11月2日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

The data sharing policy of the Janssen Pharmaceutical Companies of Johnson & Johnson is available at www.janssen.com/clinical-trials/transparency.

As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu

药物和器械信息、研究文件

研究美国 FDA 监管的药品

是的

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅